Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Id | http://purl.obolibrary.org/obo/NCIT_C933
http://purl.obolibrary.org/obo/NCIT_C933
|
---|---|
Preferred Name | Vincristine |
Definitions |
A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)
|
Type | http://www.w3.org/2002/07/owl#Class |
All Properties
definition | A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04) |
---|---|
label |
Vincristine
|
prefLabel |
Vincristine
|
Legacy Concept Name |
Vincristine
|
in_subset |
See more
See less
|
Preferred_Name |
Vincristine
|
Is_Value_For_GDC_Property | |
Is_PCDC_GCT_Permissible_Value_For_Variable | |
Chemical_Formula |
C46H56N4O10
|
Display_Name |
Vincristine
|
Maps_To |
Vincristine
|
Has_Target | |
UMLS_CUI |
C0042679
|
FDA_UNII_Code |
5J49Q6B70F
|
prefixIRI |
NCIT:C933
|
Accepted_Therapeutic_Use_For |
Lymphoma, Hodgkins, Non-Hodgkins; Malignant thymoma; Multiple myeloma; Osteogenic sarcoma; Ovarian cancer; Pheochromocytoma; Retinoblastoma; Rhabdomyosarcoma; Soft tissue sarcoma; Testicular cancer; Wilms tumor
Acute leukemia; Brain tumors; Chronic lymphocytic leukemia; Gestational trophoblastic neoplasms; Head and Neck squamous cell carcinoma; Kaposis sarcoma; Liver cancer;
|
Contributing_Source |
CTRP
FDA
PCDC
|
subClassOf | |
CHEBI_ID |
CHEBI:28445
|
Has_Salt_Form | |
code |
C933
|
type | |
ALT_DEFINITION |
The active ingredient in a drug used to treat acute leukemia. It is used in combination with other drugs to treat Hodgkin disease, non-Hodgkin lymphoma, rhabdomyosarcoma, neuroblastoma, and Wilms tumor. Vincristine is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division. It is a type of vinca alkaloid and a type of antimitotic agent.
|
Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
CAS_Registry |
57-22-7
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |